199 related articles for article (PubMed ID: 15579470)
1. Srcasm modulates EGF and Src-kinase signaling in keratinocytes.
Li W; Marshall C; Mei L; Dzubow L; Schmults C; Dans M; Seykora J
J Biol Chem; 2005 Feb; 280(7):6036-46. PubMed ID: 15579470
[TBL] [Abstract][Full Text] [Related]
2. 'Srcasm: a novel Src activating and signaling molecule.
Seykora JT; Mei L; Dotto GP; Stein PL
J Biol Chem; 2002 Jan; 277(4):2812-22. PubMed ID: 11711534
[TBL] [Abstract][Full Text] [Related]
3. Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation.
Li W; Marshall C; Mei L; Gelfand J; Seykora JT
J Biol Chem; 2007 Jan; 282(2):1161-9. PubMed ID: 17046829
[TBL] [Abstract][Full Text] [Related]
4. Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C delta.
Denning MF; Dlugosz AA; Threadgill DW; Magnuson T; Yuspa SH
J Biol Chem; 1996 Mar; 271(10):5325-31. PubMed ID: 8621384
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytes.
Nunes M; Shi C; Greenberger LM
Mol Cancer Ther; 2004 Jan; 3(1):21-7. PubMed ID: 14749472
[TBL] [Abstract][Full Text] [Related]
6. Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.
Zhao L; Li W; Marshall C; Griffin T; Hanson M; Hick R; Dentchev T; Williams E; Werth A; Miller C; Bashir H; Pear W; Seykora JT
Cancer Res; 2009 Dec; 69(24):9439-47. PubMed ID: 19934324
[TBL] [Abstract][Full Text] [Related]
7. Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk.
Van Slyke P; Coll ML; Master Z; Kim H; Filmus J; Dumont DJ
Mol Cell Biol; 2005 May; 25(9):3831-41. PubMed ID: 15831486
[TBL] [Abstract][Full Text] [Related]
8. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
9. Decreased Srcasm expression in hyperproliferative cutaneous lesions.
Meulener MC; Ayli EE; Elenitsas R; Seykora JT
J Cutan Pathol; 2009 Mar; 36(3):291-5. PubMed ID: 19220627
[TBL] [Abstract][Full Text] [Related]
10. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling.
Wong L; Deb TB; Thompson SA; Wells A; Johnson GR
J Biol Chem; 1999 Mar; 274(13):8900-9. PubMed ID: 10085134
[TBL] [Abstract][Full Text] [Related]
11. Brain-derived neurotrophic factor-, epidermal growth factor-, or A-Raf-induced growth of HaCaT keratinocytes requires extracellular signal-regulated kinase.
Rössler OG; Thiel G
Am J Physiol Cell Physiol; 2004 May; 286(5):C1118-29. PubMed ID: 15075211
[TBL] [Abstract][Full Text] [Related]
12. ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases.
Olayioye MA; Beuvink I; Horsch K; Daly JM; Hynes NE
J Biol Chem; 1999 Jun; 274(24):17209-18. PubMed ID: 10358079
[TBL] [Abstract][Full Text] [Related]
13. Src family kinase-independent signal transduction and gene induction by leukemia inhibitory factor.
Laszlo GS; Nathanson NM
J Biol Chem; 2003 Jul; 278(30):27750-7. PubMed ID: 12764151
[TBL] [Abstract][Full Text] [Related]
14. Fyn tyrosine kinase is a downstream mediator of Rho/PRK2 function in keratinocyte cell-cell adhesion.
Calautti E; Grossi M; Mammucari C; Aoyama Y; Pirro M; Ono Y; Li J; Dotto GP
J Cell Biol; 2002 Jan; 156(1):137-48. PubMed ID: 11777936
[TBL] [Abstract][Full Text] [Related]
15. Srcasm overexpression in psoriasis-insights into pathogenesis.
Pulitzer M; Li W; Hanson M; Singh F; Elenitsas R; Gelfand JM; VanVoorhees A; Seykora JT
J Cutan Pathol; 2007 Feb; 34(2):160-5. PubMed ID: 17244028
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells.
Yang CM; Lin MI; Hsieh HL; Sun CC; Ma YH; Hsiao LD
J Cell Physiol; 2005 Jun; 203(3):538-46. PubMed ID: 15573401
[TBL] [Abstract][Full Text] [Related]
17. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
Xian W; Rosenberg MP; DiGiovanni J
Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
[TBL] [Abstract][Full Text] [Related]
18. Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells.
Thelemann A; Petti F; Griffin G; Iwata K; Hunt T; Settinari T; Fenyo D; Gibson N; Haley JD
Mol Cell Proteomics; 2005 Apr; 4(4):356-76. PubMed ID: 15657067
[TBL] [Abstract][Full Text] [Related]
19. Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.
Shah BH; Yesilkaya A; Olivares-Reyes JA; Chen HD; Hunyady L; Catt KJ
Mol Endocrinol; 2004 Aug; 18(8):2035-48. PubMed ID: 15143154
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor and thrombin induced proliferation of immortalized human keratinocytes is coupled to the synthesis of Egr-1, a zinc finger transcriptional regulator.
Kaufmann K; Thiel G
J Cell Biochem; 2002; 85(2):381-91. PubMed ID: 11948693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
